Stockholm - Delayed Quote SEK
Alzinova AB (publ) (ALZ.ST)
At close: 5:29 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-16,971.0000
-15,213.0000
-10,314.0000
-9,819.7660
-6,265.7280
Investing Cash Flow
-14,622.0000
-19,604.0000
-16,633.0000
-17,321.7380
-14,903.3870
Financing Cash Flow
--
24,805.0000
30,150.0000
--
43,412.5480
End Cash Position
4,987.0000
22,026.0000
32,038.0000
28,835.5370
55,977.0410
Capital Expenditure
-14,622.0000
-19,604.0000
-16,633.0000
-17,321.7380
-14,903.3870
Issuance of Capital Stock
--
26,284.0000
36,860.0000
--
53,362.8950
Free Cash Flow
-31,593.0000
-34,817.0000
-26,947.0000
-27,141.5040
-21,169.1150
12/31/2020 - 11/25/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ELIC.ST Elicera Therapeutics AB (publ)
1.9050
-3.54%
STABL.ST Stayble Therapeutics AB (publ)
0.7200
-3.36%
ONCOZ.ST OncoZenge AB (publ)
8.89
-3.47%
EGTX.ST Egetis Therapeutics AB (publ)
4.1000
-0.97%
BINV.ST BioInvent International AB (publ)
45.00
-1.10%
BIOA-B.ST BioArctic AB (publ)
146.60
+0.55%
ISOFOL.ST Isofol Medical AB (publ)
3.3300
-4.86%
PILA.ST Pila Pharma AB (publ)
4.6700
-2.71%
ACRV Acrivon Therapeutics, Inc.
8.37
+6.90%
KRON Kronos Bio, Inc.
0.9590
+0.95%